Open AccessVenetoclax and Azacitidine in Relapsed/Refractory Acute Myeloid Leukemia and High Risk Myelodysplastic Syndrome: Bursa Uludag University Experience
Author(s) -
İbrahim Ethem PINAR,
Fahir Özkalemkaş,
Vildan Özkocaman,
Tuba Ersal,
Cumali YALÇIN,
Bedrettin ORHAN,
Ömer CANDAR
Publication year - 2021
Publication title -
turkish journal of internal medicine
Language(s) - English
Resource type - Journals
ISSN - 2687-4245
DOI - 10.46310/tjim.877068
Subject(s) - azacitidine , venetoclax , medicine , myeloid leukemia , refractory (planetary science) , hematology , complete remission , oncology , leukemia , gastroenterology , chemotherapy , chronic lymphocytic leukemia , gene expression , astrobiology , dna methylation , gene , biochemistry , chemistry , physics
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom